ARCHIVES

In Brief: NCI Will Stop Free Group C distribution Of VP-16 Sept. 1 Unless Bristol Supplies It At No Charge

This article is from The Cancer Letter archive.

Vol. 08 No. 26 | June 25, 1982

Download PDF Visit The Full Archive

Related Articles

Lenalidomide Found Effective For Lymphoma In Phase II Trial

December 26, 2008

Genentech Move Nixes Hospital Discounts: Avastin, Herceptin, Rituxan Now Sold Under Tighter Control by Drug Maker

October 3, 2014

Taxol Recommended For Second Line Therapy In Platinum-Resistant Metastatic Ovarian Cancer

November 20, 1992

NCI Drops Two CCOPS, Cincinnati And West Virginia, For Lack Of Patient Entry; 60 Funded Another Year

August 24, 1984

Annual Report to the Nation Shows Decline In Overall Cancer Death Rates

January 11, 2013

Breast Cancer action Plan Calls For More federal Coordination, Patient Participation

March 23, 1994